| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
13,088 |
10,833 |
$2.14M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,256 |
5,756 |
$6K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
77 |
52 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
6,782 |
4,065 |
$3K |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
20 |
12 |
$308.06 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
232 |
124 |
$112.50 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
4,665 |
2,408 |
$91.50 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
30 |
16 |
$6.29 |
| 81025 |
|
73 |
39 |
$2.80 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
821 |
501 |
$0.49 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
25 |
13 |
$0.00 |
| 81002 |
|
117 |
61 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
145 |
74 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
32 |
14 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
24 |
13 |
$0.00 |